Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
21.36
+0.23 (1.09%)
Jul 15, 2026, 12:03 PM EDT - Market open
Biodesix Market Cap
Biodesix has a market cap or net worth of $221.2 million as of July 15, 2026. Its market cap has increased by 502.98% in one year.
Market Cap
221.20M
Enterprise Value
264.74M
1-Year Change
502.98%
Ranking
Category
Stock Price
$21.36
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $221.20M, a decrease of -34.23%. That is a compound annual growth rate of -7.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 221.20M | 308.88% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoGenomics | 1.85B |
| Personalis | 1.57B |
| CareDx | 1.49B |
| OPKO Health | 921.21M |
| Castle Biosciences | 701.23M |
| Fulgent Genetics | 581.08M |
| Myriad Genetics | 570.47M |
| Insight Molecular Diagnostics | 144.01M |